Yokohama, Japan

Yasukatsu Yuda


Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Yokohama, JP (1992 - 1993)
  • Kanagawa, JP (1993 - 1994)

Company Filing History:


Years Active: 1992-1994

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yasukatsu Yuda: Innovator in Pharmaceutical Chemistry

Introduction

Yasukatsu Yuda is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of six patents to his name, Yuda's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Yuda's latest patents include innovative derivatives of benzothiazole and benzimidazole. One of his notable inventions is a novel benzothiazole or benzimidazole derivative that demonstrates an excellent acid secretion suppressing effect and gastric mucosa protecting effect. This compound is represented by a specific formula, wherein various substituents can be modified to enhance its efficacy as an antiulcer agent. Another significant patent involves azole derivatives and an anti-ulcerative composition containing these compounds, which also shows promise in therapeutic applications.

Career Highlights

Throughout his career, Yasukatsu Yuda has worked with reputable companies, including Meiji Seika Kabushiki Kaisha and Meiji Seika Kaisha, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceutical development.

Collaborations

Yuda has collaborated with notable colleagues in his field, including Fumiya Hirano and Tomoya Machinami. These partnerships have facilitated the exchange of ideas and fostered innovation in their research endeavors.

Conclusion

Yasukatsu Yuda's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly in the area of antiulcer agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…